San Francisco, CA (May 9, 2019) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results for the first quarter ended March 31, 2019 and provided updates on its programs. For the first quarter 2019, KindredBio reported net product revenues of $0.5 million and a […]
Thursday, August 1, 2019 Time of Event: 4:30 p.m. Eastern time/1:30 p.m. Pacific time Telephone Dial in: toll-free (855) 433-0927 from the US, or (484) 756-4262 internationally Conference ID:3784614 For more information about this event, please see the press release.
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time on Thursday, August 1, 2019. San Francisco, California (July 16, 2019) — Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, will release its second quarter 2019 financial results on August […]
Wednesday, May 22, 2019 Location: The Beverly Hilton, Beverly Hills, Room 4 Presentation time: 1:00 – 1:25 PM PT Company Attendee: Richard Chin, CEO Webcast URL: Click here For more information about this event, please see the press release.
Wednesday, May 29, 2019 Location: The Pierre Hotel, Grand Ballroom Presentation time: 10:00 – 10:25 AM ET Company Attendee: Denise Bevers, President and Chief Operating Officer Webcast URL: Click here For more information about this event, please see the press release.
Tuesday, June 4, 2019 Location: Luxe Sunset Boulevard Hotel, Bel-Air, Track 1 Presentation time: 10:20 – 10:40 AM PT Company Attendee: Richard Chin, Chief Executive Officer Webcast URL: Click here For more information about this event, please see the press release.
SAN FRANCISCO (May 13, 2019) Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, will participate in the B. Riley FBR Institutional Investor Conference taking place May 22nd in Beverly Hills, the Stifel 2019 Dental & Veterinary Conference taking place May 29th in New York, and the 9th Annual […]
Thursday, May 9, 2019 Time of Event: 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time Telephone Dial in: toll-free (855) 433-0927 from the US, or (484) 756-4262 internationally Conference ID: 5176808 For more information about this event, please see the press release.
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on Thursday, May 9, 2019 San Francisco, CA (April 25, 2019) — Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will release its first […]
San Francisco, CA (March 6, 2019) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results for the fourth quarter and full year ended December 31, 2018 and provided updates on its programs. For the fourth quarter 2018, KindredBio reported net product revenues of $1.3 […]
0.06 (0.89%)
|
||||||||||||||||
KindredBio proudly supports
Rabies Free Africa
